Olivia C. Ware
Director · Contineum Therapeutics, Inc.
Individual
- 2026
- Jun 26, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Olivia C. Ware files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rami Elghandour - $10.24M in ACLX purchases and sales in the last 12 months
- Michelle Gilson - $2.63M in ACLX purchases and sales in the last 12 months
- Christopher Heery - $1.31M in ACLX purchases and sales in the last 12 months
- Daniel S. Lorrain - $1.04M in CTNM purchases and sales in the last 12 months
- David Charles Lubner - $450K in ACLX purchases and sales in the last 12 months
- Carmine N. Stengone - $401K in CTNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Olivia C. Ware?
Olivia C. Ware is a corporate insider, tracked as Director of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Olivia C. Ware last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 2 filings going back to 2026.
